Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2004 3
2005 1
2008 4
2009 3
2010 2
2011 1
2012 1
2016 2
2017 1
2018 3
2019 4
2020 5
2021 2
2022 1
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Dopamine D1 Agonists: First Potential Treatment for Late-Stage Parkinson's Disease.
Lewis MM, Van Scoy LJ, De Jesus S, Hakun JG, Eslinger PJ, Fernandez-Mendoza J, Kong L, Yang Y, Snyder BL, Loktionova N, Duvvuri S, Gray DL, Huang X, Mailman RB. Lewis MM, et al. Among authors: gray dl. Biomolecules. 2023 May 12;13(5):829. doi: 10.3390/biom13050829. Biomolecules. 2023. PMID: 37238699 Free PMC article. Clinical Trial.
Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.
Arnsten AF, Girgis RR, Gray DL, Mailman RB. Arnsten AF, et al. Among authors: gray dl. Biol Psychiatry. 2017 Jan 1;81(1):67-77. doi: 10.1016/j.biopsych.2015.12.028. Epub 2016 Jan 18. Biol Psychiatry. 2017. PMID: 26946382 Free PMC article. Review.
Illness Phase as a Key Assessment and Intervention Window for Psychosis.
Kohler CG, Wolf DH, Abi-Dargham A, Anticevic A, Cho YT, Fonteneau C, Gil R, Girgis RR, Gray DL, Grinband J, Javitch JA, Kantrowitz JT, Krystal JH, Lieberman JA, Murray JD, Ranganathan M, Santamauro N, Van Snellenberg JX, Tamayo Z; TRANSCENDS Group; Gur RC, Gur RE, Calkins ME. Kohler CG, et al. Among authors: gray dl. Biol Psychiatry Glob Open Sci. 2022 Jun 18;3(3):340-350. doi: 10.1016/j.bpsgos.2022.05.009. eCollection 2023 Jul. Biol Psychiatry Glob Open Sci. 2022. PMID: 37519466 Free PMC article. Review.
Dopaminergic D1 Receptor Stimulation Affects Effort and Risk Preferences.
Soutschek A, Gvozdanovic G, Kozak R, Duvvuri S, de Martinis N, Harel B, Gray DL, Fehr E, Jetter A, Tobler PN. Soutschek A, et al. Among authors: gray dl. Biol Psychiatry. 2020 Apr 1;87(7):678-685. doi: 10.1016/j.biopsych.2019.09.002. Epub 2019 Sep 12. Biol Psychiatry. 2020. PMID: 31668477 Free article. Clinical Trial.
The D1/D5 Dopamine Partial Agonist PF-06412562 in Advanced-Stage Parkinson's Disease: A Feasibility Study.
Huang X, Lewis MM, Van Scoy LJ, De Jesus S, Eslinger PJ, Arnold AC, Miller AJ, Fernandez-Mendoza J, Snyder B, Harrington W, Kong L, Wang X, Sun D, Delnomdedieu M, Duvvuri S, Mahoney SE, Gray DL, Mailman RB. Huang X, et al. Among authors: gray dl. J Parkinsons Dis. 2020;10(4):1515-1527. doi: 10.3233/JPD-202188. J Parkinsons Dis. 2020. PMID: 32986682 Free PMC article. Clinical Trial.
30 results